Cardiovascular Health Profile at Age 25 Years in Adults Born Extremely Preterm or Extremely Low Birthweight

Jeanie L Y Cheong1,2,3, Anjali Haikerwal1,2, John D Wark4,5

  • 1From the Neonatal Services (J.L.Y.C., A.H., L.W.D.), Royal Women's Hospital, Parkville, Victoria, Australia.

Insights

Adults born extremely preterm or extremely low birthweight have poorer cardiovascular health at age 25. Early life weight changes and male sex are associated with less favorable cardiometabolic profiles in this group.

Area of Science:

  • Cardiology
  • Neonatology
  • Public Health

Background:

  • Prematurity and low birthweight are linked to adult cardiometabolic risk.
  • Early life predictors of this risk are not fully understood.

Purpose of the Study:

  • To compare cardiovascular health in adults born extremely preterm (EP) or extremely low birthweight (ELBW) versus controls at age 25.
  • To identify early life factors associated with cardiovascular health in EP/ELBW individuals.

Main Methods:

  • Prospective longitudinal cohort study of adults born EP/ELBW and controls.
  • Assessment of cardiovascular health profiles including anthropometry, visceral fat, blood pressure, glucose, lipids, and exercise tolerance.
  • Logistic regression and Mann-Whitney U test for statistical analysis.

Main Results:

  • Adults born EP/ELBW exhibited less favorable cardiovascular health profiles compared to controls.
  • Specific deficits in EP/ELBW group included abdominal visceral fat, blood pressure, exercise capacity, and fasting glucose.
  • Male sex and increased weight gain Z-scores in childhood/adolescence were associated with poorer cardiovascular health markers.

Conclusions:

  • Individuals born extremely preterm or extremely low birthweight face increased cardiometabolic risk in adulthood.
  • Early life growth patterns and sex influence long-term cardiovascular health outcomes.
  • Continued follow-up is essential to understand the full cardiovascular consequences.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
633
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
626
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
467
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
388
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
731
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
686